Literature DB >> 7920739

Expression of an ovine growth hormone transgene in mice increases arachidonic acid in cellular membranes.

J D Murray1, A M Oberbauer, K R Sharp, J B German.   

Abstract

The degree of unsaturation of membrane lipids has been implicated in a number of physiological disorders, yet its regulation remains poorly understood, especially the regulation of the synthesis and distribution of arachidonic acid levels, the most abundant long chain polyunsaturated fatty acid in membranes. Transgenic mice expressing the ovine metallothionein 1a-ovine growth hormone (oMt1a-oGH) fusion gene exhibited significantly elevated levels of a number of long chain polyunsaturated fatty acids in serum, including arachidonic acid. In oMt1a-oGH transgenic mice the products of all three desaturation pathways are affected by the expression of the ovine growth hormone transgene. The essential precursors of membrane long chain polyunsaturated fatty acids, 18:2n-6 and 18:3n-3, were reduced in transgenics relative to controls, and their desaturation and elongation products, arachidonic acid (20:4n-6) and docosahexaenoic acid (22:6n-3), were elevated. As rare intermediate long chain polyunsaturated fatty acids such as eicosatrienoic acid (20:3n-9) were also significantly elevated, we conclude that these observations reflect increased activity of the delta-5 and delta-6 desaturase enzymes. In contrast, the products of the stearoyl CoA or delta-9 desaturase, were significantly reduced in oMt1a-oGH expressing transgenics relative to their levels in control mice.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7920739     DOI: 10.1007/bf02336777

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  33 in total

1.  Sex-related differences in the enhancing effects of perfluoro-octanoic acid on stearoyl-CoA desaturase and its influence on the acyl composition of phospholipid in rat liver. Comparison with clofibric acid and tiadenol.

Authors:  Y Kawashima; N Uy-Yu; H Kozuka
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

Review 2.  Dietary n-3 polyunsaturated fatty acids and amelioration of cardiovascular disease: possible mechanisms.

Authors:  J E Kinsella; B Lokesh; R A Stone
Journal:  Am J Clin Nutr       Date:  1990-07       Impact factor: 7.045

3.  Sex differences in fatty acid composition of rat liver phosphatidylcholine are regulated by the plasma pattern of growth hormone.

Authors:  J Oscarsson; S Edén
Journal:  Biochim Biophys Acta       Date:  1988-04-15

4.  Regulation of expression of a sheep metallothionein 1a-sheep growth hormone fusion gene in transgenic mice.

Authors:  C M Shanahan; N W Rigby; J D Murray; J T Marshall; C A Townrow; C D Nancarrow; K A Ward
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

5.  Membrane fatty acid composition shows delta-6-desaturase abnormalities in Alzheimer's disease.

Authors:  T Nakada; I L Kwee; W G Ellis
Journal:  Neuroreport       Date:  1990-10       Impact factor: 1.837

Review 6.  Dietary lipid modification of renal disorders and ether phospholipid metabolism.

Authors:  B J Holub; D J Philbrick; A Parbtani; W F Clark
Journal:  Biochem Cell Biol       Date:  1991-07       Impact factor: 3.626

Review 7.  Effects of growth hormone on glucose metabolism.

Authors:  N Møller; J O Jørgensen; N Abildgård; L Orskov; O Schmitz; J S Christiansen
Journal:  Horm Res       Date:  1991

8.  Suppression of thromboxane A2 but not of systemic prostacyclin by controlled-release aspirin.

Authors:  R J Clarke; G Mayo; P Price; G A FitzGerald
Journal:  N Engl J Med       Date:  1991-10-17       Impact factor: 91.245

Review 9.  Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation.

Authors:  G Bazzoni; E Dejana; A Del Maschio
Journal:  Haematologica       Date:  1991 Nov-Dec       Impact factor: 9.941

10.  Regulation of insulin-like growth factor-I and binding protein-3 expression in oMtla-oGH transgenic mice.

Authors:  J C Chow; J D Murray; D Pomp; R L Baldwin; C C Calvert; A M Oberbauer
Journal:  Transgenic Res       Date:  1994-03       Impact factor: 2.788

View more
  4 in total

1.  Growth hormone enhances arachidonic acid metabolites in a growth hormone transgenic mouse.

Authors:  A M Oberbauer; J B German; J D Murray
Journal:  Lipids       Date:  2011-03-27       Impact factor: 1.880

2.  Exposure to growth hormone is associated with hepatic up-regulation of cPLA2α and COX.

Authors:  Verónica G Piazza; María E Matzkin; Nadia S Cicconi; Nadia V Muia; Sofía Valquinta; Gregorio J Mccallum; Giannina P Micucci; Thomas Freund; Elsa Zotta; Lorena González; Mónica B Frungieri; Yimin Fang; Andrzej Bartke; Ana I Sotelo; Johanna G Miquet
Journal:  Mol Cell Endocrinol       Date:  2020-04-04       Impact factor: 4.102

3.  Increased hepatic delta 6-desaturase activity with growth hormone expression in the MG101 transgenic mouse.

Authors:  M T Nakamura; S D Phinney; A B Tang; A M Oberbauer; J B German; J D Murray
Journal:  Lipids       Date:  1996-02       Impact factor: 1.880

4.  Developmental programming: the role of growth hormone.

Authors:  Anita M Oberbauer
Journal:  J Anim Sci Biotechnol       Date:  2015-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.